Stay updated on Moderna Press Releases
Sign up to get notified when there's something new on the Moderna Press Releases page.

Latest updates to the Moderna Press Releases page
- ChecktodayChange DetectedThe archive now lists three November 2026 announcements covering Moderna’s next phase of growth, real-world effectiveness data for mNEXSPIKE in older adults, and a forthcoming conference. These replace September releases about an executive role, ESMO data, and conference appearances.SummaryDifference5%

- Check7 days agoChange DetectedThe press-release listing now features November 2026 financial, vaccine authorization, and investigational vaccine updates, replacing older August announcements. The displayed stock price and trading volume have also changed.SummaryDifference5%

- Check14 days agoChange DetectedThe displayed Moderna share price and trading volume changed from $200.10 and 21.57M to $221.72 and 9.01M.SummaryDifference0.4%

- Check21 days agoChange DetectedThe news list now features Moderna’s recognition as a top employer and an upcoming presentation of Phase 3 trial results at ESMO 2026. Earlier releases about an influenza vaccine approval and an Ebola vaccine trial initiation no longer appear.SummaryDifference5%

- Check28 days agoChange DetectedModerna’s press release listing now includes an October 13, 2026 announcement that it will report third-quarter 2026 financial results on November 6, replacing the July 31 announcement about second-quarter results. The displayed stock quote and trading volume also changed.SummaryDifference1%

- Check35 days agoChange DetectedModerna’s NASD stock quote changed from $190.01 with 10.29M volume to $225.00 with 28.95M volume.SummaryDifference0.4%

Stay in the know with updates to Moderna Press Releases
Enter your email address, and we'll notify you when there's something new on the Moderna Press Releases page.